Prognostic value of emergency department testing for N-terminal fragment of brain natriuretic peptide in patients with acute heart failure: The PICASU-1 study;Valor pronóstico de la determinación urgente del péptido natriurético tipo B en los servicios de urgencies en pacientes con insuficiencia cardiaca: Estudio PICASU-1

Emergencias

Volumn 23, Issue 3, 2011, Pages 183-193

  Jacob, Javier ^a   Llorens, Pere ^b   Martín Sánchez, Francisco Javier ^c   Herrero, Pablo ^d   Álvarez, Ana ^e   Pérez Durá, María José ^f   Noval, Antonio ^g   Segura, Fernando ^h   Richard, Fernando ⁱ   Giménez, Antonio ^j   Miró, Òscar ^k,l  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^j HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

more..

Author keywords

Acute heart failure; Emergency department revisits; Emergency health services; Mortality; N terminal fragment of brain natriuretic peptide (NTproBNP)

Indexed keywords

EID: 79958030086     PISSN: 11376821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Banegas JR, Rodríguez-Artalejo J, Guallar-Castillón P. Situación epidemiología de la insuficiencia cardiaca en España. Rev Esp Cardiol. 2006;6[supl]:4C-9C.
2. Collins S, Storrow AB, Kirk JD, Pang PS, Diercks DB, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med. 2008;51:45-57.
3. Moreno-Millán E, García-Torrecillas JM, Lea-Pereira MC. Diferencias de gestión entre los ingresos urgentes y los programados en function de los grupos relacionados de diagnóstico y la edad de los pacientes. Emergencias. 2007;19:122-128.
4. Llorens P, Martín-Sánchez FJ, González-Armengol JJ, Herrero P, Jacob J, Álvarez AB, et al. Perfil clínico de los pacientes con insuficiencia cardíaca aguda en los servicios de urgencias. Datos preliminares del Estudio EAHFE (Epidemiology Acute Heart Failure Emergency). Emergencias. 2008;20:154-163.
5. Lee DS, Schull MJ, Alter DA, Austin PC, Laupacis A, Chong A, et al. Early deaths in patients with heart failure discharged from the emergency department. A population-based analysis. Circ Heart Fail. 2010;3:228-235.
6. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
7. Hsieh M, Auble TE, Yealy DM. Validation of the Acute Heart Failure Index. Ann Emerg Med. 2008;51:37-44.
8. Auble TE, Hsieh M, McCausland JB, Yealy DM. Comparison of four clinical prediction rules for estimating risk in heart failure. Ann Emerg Med. 2007;50:127-135.
9. Miró O, Llorens P, Martín-Sánchez FJ, Herrero P, Pavón J, Pérez-Durá MJ, et al. Short-term prognostic factors in elderly patients seen in emergency department for acute heart failure. Rev Esp Cardiol. 2009;62:757-764.
10. Miró O, Llorens P, Martín-Sánchez FJ, Herrero P, Jacob J, Pérez-Durá MJ, et al. Predicting the risk of reattendance for acute heart failure patients discharged from Spanish Emergency Department observation units. Eur J Emerg Med. 2010;17:197-202.
11. Escoda R, Llorens P, Martín-Sánchez FJ, Jacob J, Pavón J, Gil C, et al. Efecto de una intervención formativa en urgencias en la mejora del manejo y el tratamiento de la insuficiencia cardiaca aguda. Emergencias. 2010;22:331-337.
12. Fonarow GC, Peacock WF, Christopher CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators. Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure J Am Coll Cardiol. 2007;49:1943-1950.
13. O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7:13-20.
14. Jiménez-Navarro M, Delgado-Jiménez J, Rivera-Otero M, Roig-Minguell E, Segovia-Cubero J, Almenar-Bonet L, et al. Utilidad de los péptidos natriuréticos en la insuficiencia cardiaca. Med Clin (Barc). 2008;130:591-596.
15. Collins SP, Storrow AB. Acute heart failure risk stratification: can we define low risk? Heart Fail Clin. 2009;5:75-83.
16. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330-337.
17. Baggish AL, van Kimmenade R, Bayes-Genis A, Davis M, Lainchbury JG, Frampton C, Pinto Y, Richards MA, Januzzi JL. Hemoglobin and Nterminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study. Clin Chim Acta. 2007;381:145-150.
18. Baggish AL, van Kimmenade R, Januzzi JL. Amino-terminal pro-Btype natruiretic peptide testing and prognosis in patients with acute dysnea, including those with acute heart failure. Am J Cardiol. 2008;101[suppl]:49A-55A.
19. Januzzi JL Jr, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med. 2006;166:315-320.
20. Cavallazzi R, Nair A, Vasu T, Marik PE. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med. 2008;34:2147-2156.
21. Chen Y, Li C. Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. Am J Emerg Med. 2009;27:701-706.
22. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation. 2004;110:3206-3212.
23. Richard M., Troughton RW. NT-proBNP in heart failure: therapy decisions and monitoring. Eur J Heart Fail. 2004;6:351-354.
24. Bettencourt P, Azevedo A, Pimenta J, Friões F, Ferreira S, Ferreira A. NTerminal- pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:2168-2174.
25. Pascual-Figal DA, Cerdán-Sánchez MC, Noguera-Velasco JA, Casas-Pina T, Muñoz-Gimeno L, García-Rodríguez R, et al. Utilidad del NTproBNP en el manejo urgente del paciente con disnea severa y diagnóstico dudoso de insuficiencia cardíaca. Rev Esp Cardiol. 2005;58:1155-61.
26. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635-641.
27. Trinquart L, Ray P, Riou B, Teixeira A. Natriuretic peptide testing in EDs for managing acute dyspnea: a meta-analysis. Am J Emerg Med. 2011; en prensa.
28. Lam LL, Cameron PA, Schneider HG, Abramson MJ, Müller C, Krum H. Meta-analysis: Effect of B-Type Natriuretic Peptide Testing on Clinical Outcomes in Patients With Acute Dyspnea in the Emergency Setting. Ann Intern Med. 2010;153:728-735.
29. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625-634.
30. Januzzi JL, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. 2008;101[supl]:29A-38A.
31. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-839.
32. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005; 26: 384-416.
33. Mebazaa A, Gheorghiade M, Piña I, Harjola VP, Hollenberg S, Follath F, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008; 36 [suppl]:S129-S139.
34. Dickstein K, Cohen-Solal A, Filippatos G, McMurray J, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008;29:2388-2442.
35. Collins S, Storrow A, Kirk J, Pang P, Diecks D, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med. 2008;51:45-57.
36. Llorens P. Implicación de las nuevas guías de la Sociedad Europea de Cardiología en el tratamiento de la insuficiencia cardiaca aguda: ¿debemos cambiar nuestros esquemas en urgencias? Emergencias. 2009;21:143-147.
37. Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol. 2010;55:645-653.
38. Llorens P, Miró O, Martín Sánchez FJ, Herrero Puente PO, Jacob Rodríguez J, Gil V, et al. Manejo de la insuficiencia cardiaca aguda en los servicios de urgencias, emergencias y unidades adscritas. Emergencias. 2011;23:119-139.
39. Carratalá JM, Llorens P, Brouzet B, Carbajosa J, Albert AR, Martínez-Beloqui E, et al. Ventilación no invasiva en insuficiencia cardiaca aguda: perfil clínico y evolución de pacientes atendidos en un servicio de urgencias hospitalario. Emergencias. 2010;22:187-192.
40. Carratalá JM, Masip J. Ventilación no invasiva en la insuficiencia cardiaca aguda: uso de CPAP en los servicios de urgencias. Emergencias. 2010;22:49-55.
41. Estella A, Pérez-Bello Fontaiña L, Sánchez Angulo JI, Toledo Coello MD, Del Águila Quirós D. Actividad asistencial en la unidad de observación de un hospital de segundo nivel. Emergencias. 2009;21:95-98.
42. González-Armengol JJ, Fernández Alonso C, Martín-Sánchez FJ, González- Del Castillo J, López-Farré A, Elvira C, et al. Actividad de una unidad de corta estancia en urgencias de un hospital terciario: cuatro años de experiencia. Emergencias. 2009;21:87-94.
43. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005;45:1654-1664.
44. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring-the Home CARE pilot study. Clin Res Cardiol. 2006;95[supl 3]:29-35.
45. Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL Jr. Design and methods of the Pro-B type natriuretic peptide outpatient tailored chronic heart failure therapy (PROTECT) Study. Am Heart J. 2010;159:532-538.
46. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, et al. N-terminal pro-B-type natriuretic peptideguided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol. 2009;55:53-60.
47. Boerrigter G, Costello-Boerrigter LC, Burnett JC. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin. 2009;5:501-514.